Nothing Special   »   [go: up one dir, main page]

GB0016684D0 - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
GB0016684D0
GB0016684D0 GB0016684A GB0016684A GB0016684D0 GB 0016684 D0 GB0016684 D0 GB 0016684D0 GB 0016684 A GB0016684 A GB 0016684A GB 0016684 A GB0016684 A GB 0016684A GB 0016684 D0 GB0016684 D0 GB 0016684D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0016684A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Priority to GB0016684A priority Critical patent/GB0016684D0/en
Publication of GB0016684D0 publication Critical patent/GB0016684D0/en
Priority to US09/893,585 priority patent/US20020052370A1/en
Priority to US09/895,367 priority patent/US20020028799A1/en
Priority to EP01947709A priority patent/EP1296687A2/en
Priority to APAP/P/2001/002205A priority patent/AP2001002205A0/en
Priority to AU2001269353A priority patent/AU2001269353A1/en
Priority to EA200201071A priority patent/EA200201071A1/en
Priority to KR10-2003-7000161A priority patent/KR20030016376A/en
Priority to JP2002507770A priority patent/JP2004502670A/en
Priority to HU0301683A priority patent/HUP0301683A3/en
Priority to CA002414112A priority patent/CA2414112A1/en
Priority to NZ522368A priority patent/NZ522368A/en
Priority to HU0301660A priority patent/HUP0301660A2/en
Priority to PL36169901A priority patent/PL361699A1/en
Priority to BR0112370-0A priority patent/BR0112370A/en
Priority to IL15349201A priority patent/IL153492A0/en
Priority to KR10-2003-7000162A priority patent/KR20030017611A/en
Priority to PCT/IB2001/001205 priority patent/WO2002002513A1/en
Priority to IL15278401A priority patent/IL152784A0/en
Priority to CN01811677A priority patent/CN1438991A/en
Priority to CZ20024167A priority patent/CZ20024167A3/en
Priority to SK1818-2002A priority patent/SK18182002A3/en
Priority to JP2002508449A priority patent/JP2004502735A/en
Priority to PCT/IB2001/001187 priority patent/WO2002003995A2/en
Priority to CA002414881A priority patent/CA2414881A1/en
Priority to EP01945557A priority patent/EP1296938A1/en
Priority to NZ522931A priority patent/NZ522931A/en
Priority to AU2001267770A priority patent/AU2001267770A1/en
Priority to MXPA03000066A priority patent/MXPA03000066A/en
Priority to OA1200200396A priority patent/OA12303A/en
Priority to PE2001000662A priority patent/PE20020145A1/en
Priority to DO2001000205A priority patent/DOP2001000205A/en
Priority to GT200100131A priority patent/GT200100131A/en
Priority to HN2001000145A priority patent/HN2001000145A/en
Priority to PA20018521801A priority patent/PA8521801A1/en
Priority to SV2001000519A priority patent/SV2002000519A/en
Priority to TNTNSN01100A priority patent/TNSN01100A1/en
Priority to ARP010103212A priority patent/AR029696A1/en
Priority to UY26820A priority patent/UY26820A1/en
Priority to BG107229A priority patent/BG107229A/en
Priority to IS6601A priority patent/IS6601A/en
Priority to NO20026262A priority patent/NO20026262D0/en
Priority to MA26988A priority patent/MA26925A1/en
Priority to HR20030007A priority patent/HRP20030007A2/en
Priority to ZA200300120A priority patent/ZA200300120B/en
Priority to ECSP034417 priority patent/ECSP034417A/en
Priority to ZA200300121A priority patent/ZA200300121B/en
Priority to US11/170,397 priority patent/US20060041014A1/en
Ceased legal-status Critical Current

Links

GB0016684A 2000-07-06 2000-07-06 Pharmaceutical composition Ceased GB0016684D0 (en)

Priority Applications (48)

Application Number Priority Date Filing Date Title
GB0016684A GB0016684D0 (en) 2000-07-06 2000-07-06 Pharmaceutical composition
US09/893,585 US20020052370A1 (en) 2000-07-06 2001-06-28 Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase
US09/895,367 US20020028799A1 (en) 2000-07-06 2001-06-29 Treatment of male sexual dysfunction
EP01947709A EP1296687A2 (en) 2000-07-06 2001-07-02 Treatment of male sexual dysfunction
APAP/P/2001/002205A AP2001002205A0 (en) 2000-07-06 2001-07-02 Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase.
AU2001269353A AU2001269353A1 (en) 2000-07-06 2001-07-02 Treatment of male sexual dysfunction
EA200201071A EA200201071A1 (en) 2000-07-06 2001-07-02 CYCLOPENTYL SUBSTITUTED GLUTARAMIDE DERIVATIVES AS INHIBITORS NEUTRAL ENDOPEPTIDASE INHIBITORS
KR10-2003-7000161A KR20030016376A (en) 2000-07-06 2001-07-02 Treatment of male sexual dysfunction
JP2002507770A JP2004502670A (en) 2000-07-06 2001-07-02 Cyclopentyl substituted glutaramide derivatives as inhibitors of neutral endopeptidases
HU0301683A HUP0301683A3 (en) 2000-07-06 2001-07-02 Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral indopeptidase, their intermediates, process for their preparation, pharmaceutical compositions containing them and their use
CA002414112A CA2414112A1 (en) 2000-07-06 2001-07-02 Treatment of male sexual dysfunction
NZ522368A NZ522368A (en) 2000-07-06 2001-07-02 Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase
HU0301660A HUP0301660A2 (en) 2000-07-06 2001-07-02 Use of neutral endopeptidase inhibitors (nepi) for the treatment of male sexual dysfunction and pharmaceutical compositions comprising thereof
PL36169901A PL361699A1 (en) 2000-07-06 2001-07-02 Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase
BR0112370-0A BR0112370A (en) 2000-07-06 2001-07-02 Cyclopentyl-substituted glutaramide derivatives as neutral endopeptidase inhibitors
IL15349201A IL153492A0 (en) 2000-07-06 2001-07-02 Treatment of male sexual dysfunction
KR10-2003-7000162A KR20030017611A (en) 2000-07-06 2001-07-02 Cyclopentyl-Substituted Glutaramide Derivatives as Inhibitors of Neutral Endopeptidase
PCT/IB2001/001205 WO2002002513A1 (en) 2000-07-06 2001-07-02 Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase
IL15278401A IL152784A0 (en) 2000-07-06 2001-07-02 Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase
CN01811677A CN1438991A (en) 2000-07-06 2001-07-02 Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase
CZ20024167A CZ20024167A3 (en) 2000-07-06 2001-07-02 Glutaramide derivatives substituted with a cyclopentyl group and functioning as neural endopeptidase inhibitors
SK1818-2002A SK18182002A3 (en) 2000-07-06 2001-07-02 Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase
JP2002508449A JP2004502735A (en) 2000-07-06 2001-07-02 Treatment of male sexual dysfunction
PCT/IB2001/001187 WO2002003995A2 (en) 2000-07-06 2001-07-02 Treatment of male sexual dysfunction
CA002414881A CA2414881A1 (en) 2000-07-06 2001-07-02 Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase
EP01945557A EP1296938A1 (en) 2000-07-06 2001-07-02 Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase
NZ522931A NZ522931A (en) 2000-07-06 2001-07-02 Treatment of male sexual dysfunction
AU2001267770A AU2001267770A1 (en) 2000-07-06 2001-07-02 Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase
MXPA03000066A MXPA03000066A (en) 2000-07-06 2001-07-02 Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase.
OA1200200396A OA12303A (en) 2000-07-06 2001-07-02 Cyclopentyl-substituted glutaramide derivatives asinhibitors of neutral endopeptidase.
PE2001000662A PE20020145A1 (en) 2000-07-06 2001-07-04 DERIVATIVES OF CYCLOPENTIL-GLUTARAMIDE AS INHIBITORS OF NEUTRAL ENDOPEPTIDASE
DO2001000205A DOP2001000205A (en) 2000-07-06 2001-07-04 DERIVATIVES OF CYCLOPENTIL-GLUTARAMIDE AS INHIBITORS OF NEUTRAL ENDOPEPTIDASE
GT200100131A GT200100131A (en) 2000-07-06 2001-07-04 DERIVATIVES OF CYCLOPENTIL-GLUTARAMIDE AS INHIBITORS OF NEUTRAL ENDOPEPTIDASE.
HN2001000145A HN2001000145A (en) 2000-07-06 2001-07-04 DERIVATIVES OF CYCLOPENTIL-GLUTARAMIDE AS INHIBITORS OF NEUTRAL ENDOPEPTIDASE
PA20018521801A PA8521801A1 (en) 2000-07-06 2001-07-05 DERIVATIVES OF CYCLOPENTIL-GLUTARAMIDE AS INHIBITORS OF NEUTRAL ENDOPEPTIDASE
SV2001000519A SV2002000519A (en) 2000-07-06 2001-07-05 DERIVATIVES OF CYCLOPENTIL-GLUTARAMIDE AS INHIBITORS OF NEUTRAL ENDOPEPTIDASE REF. PCS10910ARCS / BB
TNTNSN01100A TNSN01100A1 (en) 2000-07-06 2001-07-05 GLUTARAMIDE DERIVATIVES WITH CYCLOPENTYL SUBSTITUTE, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM
ARP010103212A AR029696A1 (en) 2000-07-06 2001-07-05 DERIVATIVES OF CYCLOPENTIL-GLUTARAMIDE AS INHIBITORS OF NEUTRAL ENDOPEPTIDASE
UY26820A UY26820A1 (en) 2000-07-06 2001-07-06 DERIVATIVES OF CYCLOPENTIL-GLUTARAMIDE AS INHIBITORS OF NEUTRAL ENDOPEPTIDASE
BG107229A BG107229A (en) 2000-07-06 2002-10-29 Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase
IS6601A IS6601A (en) 2000-07-06 2002-10-29 Cyclopentyl-substituted glutamide derivatives as a neutral endopeptidase inhibitor
NO20026262A NO20026262D0 (en) 2000-07-06 2002-12-27 Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase
MA26988A MA26925A1 (en) 2000-07-06 2003-01-02 GLUTARAMIDE DERIVATIVES WITH CYCLOPENTYL SUBSTITUTE, USEFUL AS NEUTRAL ENDOPEPTIDASE INHIBITORS.
HR20030007A HRP20030007A2 (en) 2000-07-06 2003-01-03 Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase
ZA200300120A ZA200300120B (en) 2000-07-06 2003-01-06 Treatment of Male sexual dysfunction.
ECSP034417 ECSP034417A (en) 2000-07-06 2003-01-06 DERIVATIVES OF CYCLOPENTIL-GLUTARAMIDE AS INHIBITORS OF NEUTRAL ENDOPEPTIDASE
ZA200300121A ZA200300121B (en) 2000-07-06 2003-01-06 Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase.
US11/170,397 US20060041014A1 (en) 2000-07-06 2005-06-28 Treatment of male sexual dysfunction

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0016684A GB0016684D0 (en) 2000-07-06 2000-07-06 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
GB0016684D0 true GB0016684D0 (en) 2000-08-23

Family

ID=9895192

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0016684A Ceased GB0016684D0 (en) 2000-07-06 2000-07-06 Pharmaceutical composition

Country Status (4)

Country Link
EC (1) ECSP034417A (en)
GB (1) GB0016684D0 (en)
GT (1) GT200100131A (en)
ZA (2) ZA200300121B (en)

Also Published As

Publication number Publication date
ZA200300121B (en) 2004-01-21
GT200100131A (en) 2002-03-22
ECSP034417A (en) 2003-03-10
ZA200300120B (en) 2004-01-26

Similar Documents

Publication Publication Date Title
EG24357A (en) New Pharmaceutical composition
IL152659A0 (en) Pharmaceutical composition
GB2358583B (en) Pharmaceutical compositions
HK1075889A1 (en) Pharmaceutical composition
HUP0204555A3 (en) Pharmaceutical composition
HUP0300582A3 (en) Pharmaceutical compositions
AU6219601A (en) Pharmaceutical compositions
GB0009584D0 (en) Pharmaceutical compositions
AU8576801A (en) Pharmaceutical compositions
HUP0400553A3 (en) Pharmaceutical compositions
IL154238A0 (en) Pharmaceutical composition
GB0008485D0 (en) Pharmaceutical compositions
GB0009613D0 (en) Pharmaceutical compositions
GB0005382D0 (en) Pharmaceutical composition
GB0002691D0 (en) Pharmaceutical composition
GB0101094D0 (en) Pharmaceutical composition
GB0019599D0 (en) Pharmaceutical composition
GB0027375D0 (en) Pharmaceutical composition
GB0026716D0 (en) Pharmaceutical composition
GB0006301D0 (en) Pharmaceutical composition
GB0016684D0 (en) Pharmaceutical composition
GB0031288D0 (en) Pharmaceutical compositions
GB0031282D0 (en) Pharmaceutical compositions
GB0001337D0 (en) Pharmaceutical compositions
HU0700204D0 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)